S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
OTCMKTS:COTQF

Cotinga Pharmaceuticals Stock Forecast, Price & News

$0.08
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.08
Now: $0.08
$0.08
50-Day Range
$0.03
MA: $0.21
$0.70
52-Week Range
$0.01
Now: $0.08
$0.95
VolumeN/A
Average Volume1,593 shs
Market Capitalization$1.76 million
P/E RatioN/A
Dividend YieldN/A
Beta43.44
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Cotinga Pharmaceuticals logo

MarketRank

Overall MarketRank

0.42 out of 5 stars

Medical Sector

1433rd out of 1,480 stocks

Pharmaceutical Preparations Industry

606th out of 612 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:COTQF
CUSIPN/A
CIKN/A
Phone860-798-0816
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.08) per share

Profitability

Miscellaneous

Market Cap$1.76 million
Next Earnings DateN/A
OptionableNot Optionable
$0.08
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COTQF News and Ratings via Email

Sign-up to receive the latest news and ratings for COTQF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cotinga Pharmaceuticals (OTCMKTS:COTQF) Frequently Asked Questions

How has Cotinga Pharmaceuticals' stock been impacted by Coronavirus (COVID-19)?

Cotinga Pharmaceuticals' stock was trading at $0.0450 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, COTQF stock has increased by 77.8% and is now trading at $0.08.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Cotinga Pharmaceuticals?

Wall Street analysts have given Cotinga Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cotinga Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Cotinga Pharmaceuticals' earnings last quarter?

Cotinga Pharmaceuticals Inc. (OTCMKTS:COTQF) issued its quarterly earnings results on Wednesday, December, 18th. The company reported ($0.01) earnings per share for the quarter.
View Cotinga Pharmaceuticals' earnings history
.

Are investors shorting Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals saw a drop in short interest in December. As of December 31st, there was short interest totaling 1,600 shares, a drop of 96.1% from the December 15th total of 40,800 shares. Based on an average daily trading volume, of 8,500 shares, the short-interest ratio is currently 0.2 days.
View Cotinga Pharmaceuticals' Short Interest
.

Who are some of Cotinga Pharmaceuticals' key competitors?

Who are Cotinga Pharmaceuticals' key executives?

Cotinga Pharmaceuticals' management team includes the following people:
  • Ms. Alison D. Silva, CEO, Pres & Director
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 57)
  • Mr. Victor Hugo C.M.A., CPA, Chief Financial Officer (Age 51)
  • Mr. Paul Papi, VP of Investor Relations

What is Cotinga Pharmaceuticals' stock symbol?

Cotinga Pharmaceuticals trades on the OTCMKTS under the ticker symbol "COTQF."

How do I buy shares of Cotinga Pharmaceuticals?

Shares of COTQF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cotinga Pharmaceuticals' stock price today?

One share of COTQF stock can currently be purchased for approximately $0.08.

How big of a company is Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals has a market capitalization of $1.76 million.

What is Cotinga Pharmaceuticals' official website?

The official website for Cotinga Pharmaceuticals is coti.theyatesnetwork.com.

How can I contact Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals' mailing address is 127 Main Street, Boston MA, 02129. The company can be reached via phone at 860-798-0816 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.